rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2004-4-22
|
pubmed:abstractText |
Cytokeratins (CKs) have been recognized for >20 years as structural marker proteins specific for epithelial cells. Recent expression profiling analyses indicate, however, that CK down-regulation may occur in breast cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1078-0432
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2670-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15102669-Aged,
pubmed-meshheading:15102669-Breast Neoplasms,
pubmed-meshheading:15102669-Carcinoma,
pubmed-meshheading:15102669-Carcinoma, Ductal,
pubmed-meshheading:15102669-Carcinoma, Lobular,
pubmed-meshheading:15102669-Disease Progression,
pubmed-meshheading:15102669-Down-Regulation,
pubmed-meshheading:15102669-Humans,
pubmed-meshheading:15102669-Immunohistochemistry,
pubmed-meshheading:15102669-Keratins,
pubmed-meshheading:15102669-Lymphatic Metastasis,
pubmed-meshheading:15102669-Middle Aged,
pubmed-meshheading:15102669-Prognosis,
pubmed-meshheading:15102669-Protein Array Analysis,
pubmed-meshheading:15102669-Risk Factors,
pubmed-meshheading:15102669-Time Factors,
pubmed-meshheading:15102669-Tumor Markers, Biological
|
pubmed:year |
2004
|
pubmed:articleTitle |
Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer.
|
pubmed:affiliation |
Institute of Tumor Biology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|